Draft genome sequence of Catenibacterium mistuoki isolated from the fecal sample of a melanoma patient with complete response to immunotherapy
Resumen:
A strain of Catenibacterium spp. was isolated from a fecal sample of a patient diagnosed with stage IV melanoma in December 2008. The patient began treatment with the immune checkpoint inhibitor pembrolizumab in May 2016 and has since exhibited a sustained complete response to the therapy.
| 2025 | |
| ANII: FSGSK_1_2019_1_159735 | |
|
Immunotherapy Catenibactiruim Anaerobes |
|
| Inglés | |
| Universidad de la República | |
| COLIBRI | |
| https://hdl.handle.net/20.500.12008/54082 | |
| Acceso abierto | |
| Licencia Creative Commons Atribución (CC - By 4.0) |
